Merck’s efficiency program to make cuts across all businesses and regions

Monday, February 27, 2012 03:15 PM

Merck's executive board has presented initial plans for an efficiency program spanning all businesses as part of the company's comprehensive transformation program announced last year.

The efficiency program consists of two phases: In the first two years, Merck plans to set up a new leadership organization, implement efficiency measures and develop a long-term growth strategy. In the second phase, the focus will be on exploiting new growth opportunities.

"Over the next two years Merck needs to address unprecedented market shifts, increasing competition in key product areas and existing inefficiencies in its own organization to ensure the long-term success of its business model,” said Karl-Ludwig Kley, chairman of the executive board. “While it is regrettable, our preliminary analysis has shown that the overall purpose of our transformation program and the expected measures to realize it may lead to workforce reductions across all businesses and regions."

Merck will consult with employee representatives in different countries with the intention of seeking socially acceptable solutions where they are possible. Until the consultations are further along, no detailed cost or headcount reduction plans will be announced.

At the beginning of 2012, Merck started the implementation of a new leadership organization that defines the relationship of businesses, group functions and country organizations. The objective is to streamline the organizational structure to be leaner and easier to navigate and to speed up decision-making processes. The realignment will continue in parallel with and support the efficiency program.

In the second phase of the program, Merck will tap areas for future growth based on broader industry and macroeconomic trends. Initial work to explore these growth opportunities has already begun, and Merck will further drive the development of its long-term growth strategy over the next two years.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs